Viridian Therapeutics VRDN
$29.96 −$1.48 (-4.71%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $29.96 0.00%
Open$31.12
Prev close$31.44
Day range$29.87 – $31.75
Volume1.75M
Market cap$3.40B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts8
Average target$40.43+34.9% vs. price
- Buy 100%
Low $33.00Now $29.96Avg $40.43High $53.00
Recent rating changes
The last 20 actions on file set price targets from $26.00 to $53.00, averaging $37.79.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 9 Nov 2026 | Wells Fargo | BUY | $39.00 |
| 9 Nov 2026 | H.C. Wainwright | BUY | $40.00 |
| 5 Nov 2026 | Wells Fargo | BUY | $34.00 |
| 5 Nov 2026 | Wedbush | BUY | $42.00 |
| 5 Nov 2026 | Evercore | BUY | $33.00 |
| 5 Nov 2026 | H.C. Wainwright | BUY | $40.00 |
| 5 Nov 2026 | RBC Capital | BUY | $41.00 |
| 4 Nov 2026 | Wedbush | BUY | $42.00 |
| 4 Nov 2026 | Goldman Sachs | BUY | $53.00 |
| 3 Nov 2026 | Wedbush | BUY | $41.00 |
| 30 Oct 2026 | Evercore | BUY | $26.00 |
| 14 Oct 2026 | Wells Fargo | BUY | $31.00 |
| 8 Oct 2026 | RBC Capital | BUY | $38.00 |
| 2 Oct 2026 | LifeSci Capital | BUY | $35.00 |
| 22 Sep 2026 | RBC Capital | BUY | $38.00 |
| 1 Sep 2026 | Truist Financial | BUY | – |
| 19 Aug 2026 | Goldman Sachs | BUY | $40.00 |
| 13 Aug 2026 | Stifel | BUY | $40.00 |
| 11 Aug 2026 | Truist Financial | BUY | $39.00 |
| 10 Aug 2026 | Evercore | BUY | $26.00 |
No comments yet — be the first to weigh in on VRDN.
Sign in to join the discussion.